在阿尔茨海默病中准自:动物模型和机制
Xiao-Wen Zhang1, Xiang-Xing Zhu2, Dong-Sheng Tang2
1State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao 99078, China.
Zoological research
|November 14, 2023
概括
针对细胞过程自,显示出治疗阿尔茨海默病 (AD) 的前景. 本综述研究了阿尔茨海默病动物模型中的自,并讨论了阿尔茨海默病的新疗法策略.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
背景情况:
- 阿尔茨海默病 (AD) 是一种神经退行性疾病,其特点是认知能力下降.
- 自是一种细胞降解过程,涉及粉样β (Aβ) 和陶蛋白的代谢,这是AD病变的关键参与者.
- 功能失调的自会加剧AD病理,包括粉样化和团.
研究的目的:
- 审查自在阿尔茨海默氏症病原发生中的作用.
- 在已确立的AD动物模型中总结自变化.
- 为阿尔茨海默病治疗提出新的自刺激干预措施.
主要方法:
- 关于阿尔茨海默病中自的研究的文献综述.
- 在代表性AD动物模型中对自的病理变化的分析.
- 对针对AD模型中自的最近治疗策略的评估.
主要成果:
- 自功能障碍是阿尔茨海默氏症病理学的重要特征.
- 动物模型揭示了与AD相关的自途径的特定变化.
- 刺激自的新兴干预措施在临床前AD模型中显示出潜力.
结论:
- 调节自是一种对阿尔茨海默病有前途的治疗途径.
- 对自机制和有针对性的干预措施的进一步研究对于AD治疗至关重要.
- 了解AD动物模型中自的作用可以指导临床应用.
更多相关视频
08:01Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
42.5K
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
8.0K
相关概念视频
01:22Alzheimer's Disease: Treatment
197
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
197
01:26Alzheimer's Disease: Overview
498
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
498